Sign in

You're signed outSign in or to get full access.

Matthew C. Lucey

Matthew C. Lucey

President and Chief Executive Officer at PBF EnergyPBF Energy
CEO
Executive
Board

About Matthew C. Lucey

Matthew C. Lucey, age 51, is President & Chief Executive Officer of PBF Energy and a director since July 2023; he previously served as President (2015–2023), EVP (2014), CFO (2010–2014), and VP Finance (since 2008), with prior experience as a Managing Director at M.E. Zukerman & Co. and six years in banking . Under Lucey’s tenure, PBF’s long-term incentive plan paid the 2021 PSU/PU cycle at 200% based on three‑year TSR of 142.31% vs peers (1/1/2022–12/31/2024), evidencing strong relative value creation despite a challenging 2024 operating backdrop and zero CIP payout for 2024 due to missing Adjusted EBITDA threshold .

Past Roles

OrganizationRoleYearsStrategic Impact
PBF EnergyPresident & CEO; DirectorSince Jul 2023Led operational recovery initiatives and strategic portfolio reviews; maintained dividend and buybacks .
PBF EnergyPresidentJan 2015–Jun 2023Oversaw multi-refinery operations and growth initiatives .
PBF EnergyExecutive Vice PresidentApr 2014–Dec 2014Senior leadership across enterprise .
PBF EnergySenior Vice President, CFOApr 2010–Mar 2014Built finance function through cycles; capital markets stewardship .
PBF EnergyVice President, FinanceApr 2008 onwardEarly leadership; helped institutionalize finance .

External Roles

OrganizationRoleYearsStrategic Impact
M.E. Zukerman & Co. (PE firm)Managing Director2001–2008Led energy investments; served on management committees of Penreco, Cortez Pipeline Company, Venture Coke Company .
Banking industryVice President/Associate (roles not specified)Six years (dates not disclosed)Core finance/banking expertise supporting later CFO role .

Fixed Compensation

Metric202220232024
Base Salary ($)670,000 990,000 (reflects mid-year CEO transition) 1,250,000
Target Annual Bonus (% of Salary, CIP)150% 150% 150%
Actual Annual Cash Incentive ($)Paid under program as applicable (detail not itemized) — (CIP payout not shown; special bonus below) 0 under CIP; Special cash bonus $890,000 (strategic initiatives)
Stock Awards Grant-Date Fair Value ($)2,765,573 7,836,098 5,836,243
Total Compensation ($)5,933,116 12,240,872 8,837,500

Notes:

  • Compensation program emphasizes at‑risk pay and TSR-based long-term incentives; clawback in effect since Oct 2, 2023 .

Performance Compensation

ComponentMetricWeightThresholdTargetMaximum2024 ActualPayout
CIP FinancialAdjusted EBITDA ($)90% >816M 1.05B 1.23B 86.5M 0% for NEOs (threshold not met)
CIP ESGLTIR (employees + contractors)2.5% 0.20 0.15 0.10 0.09 No payout due to EBITDA miss
CIP ESGTier 1 Events2.5% 10 6 4 9 No payout due to EBITDA miss
CIP ESGFederal flaring events (>500 lbs SO2)2.5% 12 9 6 25 No payout due to EBITDA miss
CIP ESGDiscretionary HSE2.5% N/A N/A N/A N/A N/A
LTIRestricted Stock (2024 grants)40% of LTI mix 83,854 shares (CEO) Ratable vest over 3 years
LTIPerformance Share Units (2024 grants)30% of LTI mix 0%100%200% 53,089 units (CEO) 3-year cliff; TSR peer-relative with negative TSR cap
LTIPerformance Units (cash) (2024 grants)30% of LTI mix $0.00$1.00$2.00 2,918,122 units (CEO) 3-year cliff; TSR peer-relative

Additional realized performance:

  • 2021 PSU/PU cycle (measured 1/1/2022–12/31/2024): TSR 142.31%, Rank 1; payout 200% with dividend equivalents; CEO received 61,897 shares from PSUs and $2,240,182 from PUs .

Equity Ownership & Alignment

ItemValueDetail
Beneficial Ownership (as of Mar 7, 2025)1,314,724 shares; 1.1% of common259,123 directly; 138,417 restricted (non-dividend, vote eligible); 69,198 PBF LLC Series A Units; 847,986 shares acquirable within 60 days via warrants/options .
Stock Ownership Guidelines6x base salary for CEO; all NEOs metMust hold 50% of net shares until guideline met; 1-year post‑vesting/exercise holding requirement for NEOs on awards granted after June 2022 .
Hedging/PledgingProhibitedPolicy forbids hedging/pledging/short selling by directors/employees .
Outstanding Equity (12/31/2024)Options exercisable: multiple tranches; RS and PSUs unvestedCEO options: 120,000 @ $30.89 exp 10/27/2025; 120,000 @ $21.38 exp 10/25/2026; 120,000 @ $28.67 exp 10/30/2027; 167,298 @ $40.65 exp 10/30/2028; 105,473 @ $32.71 exp 10/29/2029; 142,364 @ $6.72 exp 11/9/2030; 72,851 @ $13.91 exp 11/18/2031 .
Unvested Restricted Stock9,235; 45,328; 83,854 (by grant cohort)9,235 vesting 12/2/2025; 45,328 vesting in two annual tranches starting 10/27/2025; 83,854 vesting in three annual tranches starting 12/16/2025 .
Unearned PSUs/Units (market/payout value)53,089 PSUs ($1,409,513); 41,927 PSUs ($1,156,137); 16,584 PSUs ($471,400); 2,918,122 PUs ($2,918,122); 3,984,440 PUs ($3,984,440); 1,359,560 PUs ($1,359,560)Per outstanding awards table; cash units settle at $0–$2 per unit based on TSR .
2024 Exercises/Vesting50,000 options exercised; 22,664 + 9,236 RS vested; 61,897 PSUs vestedRealized values: $1,302,000 on 50k option exercise; RS vest values $346,397 and $751,992; PSU vest value $1,643,365 (using $26.55 close) .

Insider selling pressure indicators:

  • Upcoming vesting dates (Dec 2, 2025; Oct 27, 2025; Dec 16, 2025) may create sell‑to‑cover activity due to holding and net share retention requirements .
  • Multiple near-term option expirations (2025–2029) could prompt exercises tied to market levels; hedging/pledging is prohibited, which reduces leverage risks .

Employment Terms

ProvisionKey Terms
Term and RenewalOne‑year term with automatic one‑year renewals unless 30‑day non‑renewal notice by either party .
Severance (no CIC)1.5x base salary lump sum; 18 months health benefit continuation; accelerated vesting of certain equity at 100% for PSUs/PUs; non-compete 6 months; release required .
Change‑in‑Control (CIC) (double trigger)2.99x salary lump sum; immediate vest of options and awards; 2 years 11 months health continuation; defined CIC events include >50% voting power change, asset sale, merger, liquidation, board turnover; excludes specific “Excluded Entities” .
Death/Disability0.5x salary; pro‑rata target annual bonus; accelerated equity value .
ClawbackCompany‑wide clawback effective Oct 2, 2023 for accounting restatements; plan-level clawbacks on awards; restrictive covenants (non‑compete, non‑solicit, confidentiality) apply; violations can cause forfeiture .
Tax Gross‑UpsNone; payments reduced to avoid excise tax under IRC §4999 .

Potential payouts (illustrative, as of 12/31/2024):

  • Termination without cause/good reason: Cash severance $1,875,000; health $43,242; accelerated equity $15,051,099 .
  • CIC termination: Cash severance $3,737,500; health $84,081; accelerated equity $15,051,099 .
  • Death/Disability: Cash $625,000; target bonus $1,625,000; accelerated equity $15,051,099 .

Board Governance

  • Board service: Lucey is a non‑independent director and CEO since July 2023; Board currently has 10 members with 8 independent directors; all directors attended ≥75% of meetings in 2024 .
  • Leadership structure: Chairman and CEO roles separated; Executive Chairman Thomas J. Nimbley transitions to non‑executive Chairman effective July 1, 2025, enabling CEO focus on execution .
  • Lead Independent Director: S. Eugene Edwards leads executive sessions and liaises between independents and Chair; independent directors meet in executive session regularly (typically before every Board meeting) .
  • Committees: Audit, Compensation, Nominating & Corporate Governance, HS&E—all independent membership; chairs refreshed since 2023 .
  • Employee director compensation: Employee directors receive no separate director compensation; Lucey’s compensation disclosed in NEO tables .
  • Say‑on‑Pay: 97.30% approval at 2024 Annual Meeting .

Compensation Committee & Peer Benchmarking

  • Philosophy: Heavy variable pay, TSR‑based LTI (60% of LTI in performance awards), one three‑year measurement period, negative TSR cap limiting upside when absolute TSR is negative .
  • Consultant: Pay Governance LLC engaged as independent adviser; no conflicts disclosed .
  • Peer groups: Compensation benchmarked to a 2024 Refining Peer Group with ≥35% discount for size and a Secondary Reference Group; CEO’s 2024 total compensation below median of both .

Director Compensation (for context; Lucey is employee director)

  • Non‑employee director stock ownership guideline: ≥3x annual cash retainer; five years to comply; long‑tenured directors met guidelines .
  • Employee directors (CEO) receive no separate Board compensation .

Performance & Track Record

  • 2024 performance: Challenging macro, narrower light‑heavy diffs, unscheduled maintenance and turnarounds increased costs; result: CIP EBITDA threshold not met; no 2024 CIP payout to NEOs .
  • Strategic actions: Initiated Refining Business Improvement Initiative targeting ≥$200 million cash savings by end-2025; dividends increased to $0.275/qtr in Oct 2024; continued buybacks; strategic review of logistics/real estate assets .
  • 2025 updates: Martinez fire, insurance recoveries ($500M unallocated net through Q3), terminal asset sale ($175.4M), dividend maintained, detailed throughput guidance; adjusted metrics provided .

Risk Indicators & Red Flags

  • Alignments: No hedging/pledging; stock holding requirements; clawback in place; no option repricing; no excise tax gross‑ups .
  • Discretionary bonuses: Special cash bonuses paid despite zero CIP payout may raise pay‑for‑performance scrutiny; Board cites leadership in strategic initiatives as rationale .
  • Related party transactions: None significant involving directors or officers .
  • Insider activity: 2024 exercises/vesting disclosed; recent Form 4s for Lucey not found in our search; selling pressure likely around scheduled vesting/exercise dates . (We searched for Form 4 filings and found no matching entries.)

Investment Implications

  • Alignment: CEO’s equity-heavy package, strict ownership/holding rules, and TSR‑based LTI with a negative TSR cap support shareholder alignment; 200% PSU/PU payout for the 2021 cycle underscores strong relative value creation .
  • Near-term technicals: Multiple option tranches are exercisable with expirations beginning in late 2025; sizable unvested RS/PSU/PU cohorts have specific vest dates in Q4 2025, which can drive sell‑to‑cover flows; hedging/pledging prohibitions limit risk-taking via leverage .
  • Retention/CIC: Double‑trigger CIC at 2.99x salary with full acceleration and long non‑renewal health continuation suggests strong retention and potential costs in a control change; clawback and covenants mitigate misconduct risk .
  • Governance: Separation of Chair/CEO, robust independent committee structure, high say‑on‑pay support, and independent consultant use reduce dual‑role concerns with CEO as director .